@FierceBiotech: ICYMI yesterday: First successful transplant of retinas made from embryonic stem cells. Article | Follow @FierceBiotech
@JohnCFierce: Report: Big Pharma mounts secret attack against data transparency rule (some companies will never learn). ICYMI yesterday | Follow @JohnCFierce
@RyanMFierce: Biogen sees 'unlikely' link between Tecfidera and patient death. Story | Follow @RyanMFierce
> Regulus Therapeutics priced its public offering of 4.5 million shares of common stock at $9.50 per share. Release
> Quest PharmaTech has partnered with AD Biotech to share research and technology development resources. AD Biotech has provided $2 million of clinical development funding to Quest and has agreed to provide up to $10 million of additional funding in return for Quest common shares and future revenue sharing. Release
> Imprimis Pharmaceuticals ($IMMY) has acquired intellectual property for IPI-120, an antibiotic drug candidate to treat bleeding and clotting. Release
@FierceMedDev: Oxford University blood test designed to screen for stress. Item | Follow @FierceMedDev
@MarkHFierce: Google is the lead in SynapDx's $15.4M funding round - the trial for its autism Dx blood test is now under way. ICYMI yesterday | Follow @MarkHFierce
@DamianFierce: The FDA has changed its approach to medical device hackers, part of its new commitment to cybersecurity. Report | Follow @DamianFierce
> JenaValve lands $62.5M round for heart valve. More
> Baxter wins EU sign-off for $4B Gambro deal. News
> Medical devices help spur Israeli VC investment growth. Article
Pharma News
@FiercePharma: Some good news for Forest Labs: Quarterly sales tick up 6% to almost $800M; Forest credits newer products. More | Follow @FiercePharma
@CarlyHFierce: Former AstraZeneca exec Tony Zook officially in as new CEO of Vivus. News | Follow @CarlyHFierce
> China detains first U.S. citizen in pharma industry probe. Story
> GlaxoSmithKline forges ahead with hunt for Chinese vaccine partners. Article
> Biogen: Tecfidera link to MS patient's death 'unlikely.' Report
Biotech Research News
@EmilyMFierce: Novartis MS drug prevents heart failure in animal study. Article | Follow @EmilyMFierce
> Retinas made from embryonic stem cells implanted into mice for the first time. News
> New 3-D model of diabetes target could shape drug design. Story
> Neural origins of menopausal hot flashes discovered. Item
> Revalesio drug alters Alzheimer's progression in animal model. Article
Pharma Manufacturing News
@EricPFierce: Orphan drugs have become a key product for many companies. See why: Special report | Follow @EricPFierce
> Wockhardt FDA warning letter says QA staff tried to mislead inspectors. Report
> Drug shortages in Ireland getting worse. More
> New bill could free drug user fees from sequestration, improve oversight. Article
> Venus Remedies gets 9 Ukraine plants approved. Item
> AMRI gets issues under control at Burlington plant. Report
And Finally... A drug sold by Novartis ($NVS) to treat multiple sclerosis could potentially prevent heart failure. Story